Caribou Biosciences: Funding, Investors & Team (Sep 2026)
Caribou Biosciences operates a medical technology company focused on analyzing cell and genome engineering. The company specializes in utilizing the CRISPR-Cas9 technology platform, along with guide RNA, to modify double-stranded DNA. This capability enables the creation of targeted changes to DNA, thereby facilitating the development of therapeutics for various sectors such as agricultural biotechnology, industrial biotechnology, and biological research, both at a basic and applied level.
Caribou Biosciences has raised $240M across 2 funding rounds on record, the most recent an undisclosed round of $125M announced in Jul 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Caribou Biosciences Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Caribou Biosciences Funding Rounds
Caribou Biosciences raised $115M in a Series C announced in Mar 2021.
2.3 years later, an undisclosed round of $125M was announced in Jul 2023.
Caribou Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Caribou Biosciences Funding Compared to Other Biotechnology Startups
Caribou Biosciences' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Caribou Biosciences in Biotechnology and Berkeley
Companies Similar to Caribou Biosciences
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Caribou Biosciences Funding FAQs
What does Caribou Biosciences do?
Caribou Biosciences operates a medical technology company focused on analyzing cell and genome engineering. The company specializes in utilizing the CRISPR-Cas9 technology platform, along with guide RNA, to modify double-stranded DNA. This capability enables the creation of targeted changes to DNA, thereby facilitating the development of therapeutics for various sectors such as agricultural biotechnology, industrial biotechnology, and biological research, both at a basic and applied level.
How much funding has Caribou Biosciences raised?
Caribou Biosciences has raised $240M across 2 rounds on record. The most recent is an undisclosed round of $125M announced in Jul 2023.
When did Caribou Biosciences last raise funding?
Caribou Biosciences' most recent funding round on record is an undisclosed round of $125M, announced in Jul 2023.
Who founded Caribou Biosciences?
FundedIQ lists James Berger (Founder) at Caribou Biosciences.
Who is the CEO of Caribou Biosciences?
Rachel Haurwitz is listed as CEO at Caribou Biosciences.
Where is Caribou Biosciences headquartered?
Caribou Biosciences is based in Berkeley, California, United States.
How many employees does Caribou Biosciences have?
Caribou Biosciences is in the 101-250 employee band.
How does Caribou Biosciences' funding compare to other Biotechnology startups?
Caribou Biosciences' latest round of $125M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Caribou Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Caribou Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.